Elucidation of Novel Therapeutic Targets for Breast Cancer with <i>ESR1-CCDC170</i> Fusion
Among the various types of breast cancer, the luminal B subtype is the most common in young women, and <i>ESR1-CCDC170</i> (E:C) fusion is the most frequent oncogenic fusion driver of the luminal B subtype. Nevertheless, treatments targeting E:C fusion has not been well established yet....
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-02-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/10/4/582 |